通过实施时间和覆盖率来评估COVID-19疫苗接种对日本错误信息传播率的影响
Yuki Furuse1, Takahiro Tabuchi2
1Department of Microbiology and Infection, The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan; Department of Medical Virology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Vaccine
|May 21, 2025
概括
在日本,COVID-19疫苗的推出时间显著影响了死亡率. 早期实施避免了成千上万的死亡,证明有效的疫苗接种策略的时间比覆盖率更为关键.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 数学建模的数学建模
背景情况:
- 在全球范围内,COVID-19疫苗对于拯救生命至关重要.
- 疫苗实施策略,包括时间和覆盖范围,在各国各不相同.
- 错误信息对像疫苗接种这样的公共卫生干预构成了重大挑战.
研究的目的:
- 评估COVID-19疫苗实施时间和覆盖范围对日本死亡率的影响.
- 评估错误信息管理对疫苗接种覆盖率和结果的影响.
- 探索反事实场景,以优化疫苗推广策略.
主要方法:
- 开发一个数学模型,整合COVID-19病例,疫苗接种数据,疫苗有效性和变体比例.
- 重新分析关于错误信息信念和对疫苗接种态度的调查数据.
- 基于不同的疫苗实施时间表,覆盖率和错误信息影响的反事实场景的模拟.
主要成果:
- 据估计,在2021年,接种疫苗在日本避免了大约30,117例COVID-19死亡.
- 疫苗实施延迟3个月与22216例额外死亡有关.
- 改进的错误信息管理可以将覆盖率提高到88.0%并避免431例死亡,而糟糕的管理可以将覆盖率降低到76.6%,并将死亡率增加到1020.
结论:
- 疫苗实施时间显示,对COVID-19死亡率的影响比仅仅疫苗接种覆盖率更大.
- 有效地管理错误信息对于最大限度地提高疫苗接种覆盖率和减轻死亡率至关重要.
- 优化疫苗接种策略需要仔细考虑推广时间和主动控制错误信息.
相关概念视频
01:51Vaccinations
43.3K
Overview
43.3K
01:29Bias in Epidemiological Studies
115
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
115
01:08Prevalence and Incidence
286
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
286
01:27Confounding in Epidemiological Studies
121
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
121
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
01:21Causality in Epidemiology
220
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
220